fda tirzepatide shortage resolved 2025 resolves shortage, impacting compounding pharmacies is semaglutide on the shortage

How Tirzepatide May Cause Headache Tirzepatide acts on GLP-1 receptors and GIP receptors to regulate appetite and digestion

Weight Loss Management & Medication Patients who are overweight or obese are at higher risk of developing chronic diseases such as diabetes, high blood pressure, heart disease, and some cancers

Some of the serious side effects of this medication include pancreatitis, diabetic eye problems, severe low blood sugar, and allergic reaction

On the one hand, some studies capture dysgeusia or taste disorder as adverse events (AEs) (66), which may reflect abnormal sensation or treatment-related discomfort

But I think people have to look beyond the weight loss benefits of these drugs, he added

Obesity rates in most regions are on the rise particularly in China and India, where many are edging away from traditional Asian diets to more calorific western-style food